Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Neuroscientists receive ERC Synergy Grant to explore the neural basis of cognition

Neuroscientists receive ERC Synergy Grant to explore the neural basis of cognition

Novel insights on a common protein could have broad biomedical applications

Novel insights on a common protein could have broad biomedical applications

New treatment method could be more effective for Alzheimer's disease

New treatment method could be more effective for Alzheimer's disease

Researchers use new approach to study the mechanisms of cellular uptake of amyloid beta

Researchers use new approach to study the mechanisms of cellular uptake of amyloid beta

New articles focus on policy considerations for post-COVID presidency

New articles focus on policy considerations for post-COVID presidency

Root bacterium could provide a new approach for treatment of Alzheimer's

Root bacterium could provide a new approach for treatment of Alzheimer's

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

The road to achieving single molecular spectroscopy using nanoIR

The road to achieving single molecular spectroscopy using nanoIR

Researchers identify distinct link between autism and brain cell abnormalities

Researchers identify distinct link between autism and brain cell abnormalities

RNI researchers to study the impact of excessive speeds on the human brain, body

RNI researchers to study the impact of excessive speeds on the human brain, body

Research projects receive BTCA grants to develop novel drugs for various diseases

Research projects receive BTCA grants to develop novel drugs for various diseases

Research program aims to thwart prion-like spread of tau pathology in Alzheimer’s disease

Research program aims to thwart prion-like spread of tau pathology in Alzheimer’s disease

Study finds no association between leisure activities and lower dementia risk

Study finds no association between leisure activities and lower dementia risk

Antiseizure drug use during pregnancy linked with double the risk of having children with autism

Antiseizure drug use during pregnancy linked with double the risk of having children with autism

Grant programs will provide $2.2 million to support biomedical research on healthy aging

Grant programs will provide $2.2 million to support biomedical research on healthy aging

'White matter lesion' mapping tool can detect early signs of cognitive decline

'White matter lesion' mapping tool can detect early signs of cognitive decline

Interaction between PTSD and klotho gene may cause premature aging in the brain

Interaction between PTSD and klotho gene may cause premature aging in the brain

Researchers generate a transcriptomic map of the COVID brain

Researchers generate a transcriptomic map of the COVID brain

$109 million NIH grant awarded to expand Alzheimer's disease and Down syndrome research

$109 million NIH grant awarded to expand Alzheimer's disease and Down syndrome research

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.